"Give it thirty days" is sometimes an accurate description of how a compound works and sometimes a way of getting past a return window. The two are distinguishable, and the distinction rests on arithmetic that is printed nowhere on a package.
One of the fastest nutrient results on record
In May 1747, aboard HMS Salisbury, James Lind divided twelve sailors with scurvy into six pairs and gave each pair a different treatment. One pair got two oranges and a lemon a day.
Within about six days that pair had improved so far that one man was fit for duty and the other was nursing the rest.
Six days. It is worth holding that against every modern instruction to be patient, because the speed of a nutrient effect is a property of the deficiency being corrected, not a matter of the reader's persistence.
Two clocks, running at different speeds
The first clock is pharmacokinetic: how fast a compound is absorbed, how long it stays, and how many doses it takes to reach a stable concentration.
The second is biological: how long the thing being changed takes to change. Rebuilding a blood cell population is slower than occupying a receptor, and no dosing schedule can hurry it.
Almost every misleading claim about timing comes from quoting one clock and implying the other.
The first clock, in arithmetic
Most compounds are cleared at a rate proportional to how much is present, which is what "half-life" describes. Repeated dosing then builds toward a plateau on a fixed schedule.
After one half-life a repeated dose has reached half its eventual steady level, after two it has reached three-quarters, and by four or five it is within a few per cent of the plateau. That is why "four to five half-lives" is the standard answer to how long a regimen takes to settle.
Steady state, worked through
| Half-lives elapsed | Share of steady state | If the half-life is 1 hour | If the half-life is 5 hours |
|---|---|---|---|
| 1 | 50% | 1 hour | 5 hours |
| 2 | 75% | 2 hours | 10 hours |
| 3 | 87.5% | 3 hours | 15 hours |
| 4 | 93.8% | 4 hours | 20 hours |
| 5 | 96.9% | 5 hours | About one day |
What that looks like on real compounds
L-theanine: hours
Peak plasma concentration at roughly 50 minutes, with a half-life on the order of an hour (van der Pijl et al., Journal of Functional Foods, 2010; n=6 healthy adults, 25 to 200 mg).
Nothing with that profile accumulates. Whatever it does, it does on the day it is taken — which is why the sleep and attention research on it is built from acute measurements, as set out in L-theanine and sleep.
Caffeine: about a day
Half-life in healthy adults averages around five hours, with wide individual variation (Fredholm et al., Pharmacological Reviews, 1999; review of human pharmacokinetics). Daily intake therefore reaches steady state within about a day.
Vitamin B12: years
The body holds a store of a few milligrams, mostly in the liver, and loses a very small fraction of it daily. When absorption stops completely — after total removal of the stomach, for instance — deficiency takes years to appear.
Which makes B12 the clearest case of the two clocks disagreeing. The compound is absorbed within hours and the store it feeds turns over across years, as described in B12 and the nervous system.
The second clock: what is being measured
Anything counted in red blood cells takes months
A red cell lives about 120 days. Any marker carried inside them — glycated haemoglobin reflects roughly the preceding eight to twelve weeks — cannot move faster than the population turns over, whatever is swallowed.
Some responses are much faster
Start treating a B12 deficiency and the bone marrow's output of new red cells rises within days, peaking around the end of the first week, while the haemoglobin level takes about two months to normalise.
One intervention, two answers to "how long", depending entirely on which number is being watched.
Which is why trial timepoints differ so wildly
A lion's mane study measured a speeded task 60 minutes after a single dose and cognitive outcomes at 28 days (Docherty et al., Nutrients, 2023; n=41, healthy adults aged 18–45). Another ran 16 weeks, then measured again four weeks after stopping and found the scores had fallen back (Mori et al., Phytotherapy Research, 2009; n=30, mild cognitive impairment).
A zinc trial ran six months (Maylor et al., British Journal of Nutrition, 2006; healthy adults aged 55–87). A B-vitamin cognition trial ran two years (McMahon et al., New England Journal of Medicine, 2006; n=276).
The timepoint encodes the hypothesis. Reading it backwards is the most reliable way to work out what the researchers thought they were measuring — including in lion's mane and nerve growth factor, where the discontinuation measurement is the most informative number in the study.
The design that answers the question directly, and is almost never run
Give a supplement, measure, then take it away and measure again. If the effect decays on withdrawal it was being sustained by the product; if it holds, something else was doing the work.
That is the single most informative thing a supplement trial can do, and across the ingredients on this site exactly one published study did it — the sixteen-week lion's mane trial, which measured again four weeks after stopping and found the gain had gone.
It is not run more often because it is expensive, it lengthens the study, and a null on withdrawal is commercially unwelcome. A reader looking for one signal of study quality could do worse than to check for it.
So where does "thirty days" come from
The version that is honest
For an endpoint that turns over on a scale of weeks, a month is a reasonable minimum interval before asking whether anything has changed. Several of the trials above would have reported nothing at day seven.
The version that is commercial
Thirty days is also, and not coincidentally, the length of a standard subscription cycle and slightly longer than many return windows. A period the customer is asked to wait out is a period during which nothing can be returned.
Ours is a 30-day pouch with a 30-day return window, and those two numbers were not chosen independently of each other. Stating that is more useful than pretending the alignment is a coincidence.
Two reasons a thirty-day self-assessment misleads
People start at their worst
Nobody buys a focus supplement during a good month. Measurements taken from an unusually low starting point tend to drift back toward that person's average regardless of what was taken. That is regression to the mean, a statistical effect rather than a psychological one.
Placebo bites hardest exactly here
A review of 114 randomised trials comparing placebo against no treatment at all found little effect on objective binary outcomes, but measurable effects on continuous subjective ones such as reported pain (Hróbjartsson and Gøtzsche, New England Journal of Medicine, 2001).
"How clear the week felt" is a continuous subjective outcome assessed by someone who paid for the bottle. That is the worst-case configuration for self-assessment, and it is the only configuration available at home.
Three questions that sort one from the other
Does the mechanism require anything to accumulate? If the compound clears in an hour and nothing is being built up, a four-week wait has no pharmacological justification.
When did the published trials take their measurements? A study that measured at 60 minutes is describing a different product from one that measured at 16 weeks, even if the capsule is identical.
Is there a discontinuation result? A study that measured again after stopping is worth several that did not, because it shows whether anything was being sustained.
What that gives for this formula, ingredient by ingredient
L-theanine clears within hours and does not accumulate. Zinc and B12 are cover for a dietary shortfall, and shortfalls are corrected on the timescale of the store being refilled, which is weeks for one and much longer for the other — the reasoning in why a zinc shortfall is more common than it sounds.
Lion's mane was studied over weeks in its published trials, which is a description of how those studies were designed rather than a promise about what happens at the end of them. Alpha-GPC is the less tidy case: most of the evidence in healthy adults reports physical and psychomotor outcomes over days, and the longer work was conducted in dementia and cerebrovascular populations rather than in healthy ones. The dose and duration record is in how much alpha-GPC the research actually used.
Where we stand
Weal Focus is a 60-capsule pouch taken two a day, which is thirty days, with a 30-day return window. The trial you can run on yourself lasts exactly as long as the window in which you can send it back. Both numbers are stated on the page rather than explained by a promise about when results arrive.
No timeline is offered here for when anything should be noticed, because the answer differs per ingredient and, for the two most interesting ones, has not been established in healthy adults at all. What a reader can do is make their own thirty-day assessment harder to fool: write down two or three specific things before starting rather than after, judge them at the same time of day, and note what else changed that month. It will not turn a kitchen into a trial, but a judgement written down in advance is harder to revise afterwards than one made from memory.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Sources for the claims and figures on this page, with the population studied in each, are on our citations page.